This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of chiral molecules, particularly in the production of drugs that require specific stereochemistry for efficacy. Its structure is often leveraged in the creation of compounds targeting neurological and psychiatric disorders, where precise molecular configurations are essential for binding to specific receptors. Additionally, it is employed in research settings for the development of new therapeutic agents, particularly in the field of medicinal chemistry, where its chiral centers are valuable for studying structure-activity relationships.